文献速递糖尿病

2型糖尿病心衰住院与主要动脉粥样硬化事件发生率比较:心血管结局试验荟萃分析

Incidence of Hospitalization for Heart Failure Relative to Major Atherosclerotic Events in Type 2 Diabetes: A Meta-analysis of Cardiovascular Outcomes Trials.
PubMed 文献 · Diabetes Care · 2020-01-01

结果显示,在大多数试验中HHF发生率低于心肌梗死但高于卒中;在慢性肾病富集人群中HHF比心肌梗死和卒中更常见。结论认为HHF是2型糖尿病常见事件,无论有无既往心血管疾病。

要点

  • 在14项非肾病富集试验中,13项(93%)HHF发生率低于心肌梗死,8项(57%)差异显著。
  • HHF在除1项外的所有试验中超过卒中(93%),其中7项(50%)差异显著。
  • 2项慢性肾病富集试验中,HHF比心肌梗死和卒中更常见。

核心结论

  • 尽管HHF发生率低于心肌梗死,但HHF是2型糖尿病患者的常见事件,无论有无既往心血管疾病。

主要发现

  • 在2项慢性肾病富集试验中,HHF比心肌梗死和卒中更常见。
  • 在其余14项试验中,13项(93%)HHF发生率低于心肌梗死,其中8项(57%)差异显著。
  • 在除1项外的所有试验中(93%),HHF超过卒中,其中7项(50%)差异显著。
  • 试验间异质性为中/高度(I² > 50%),部分由HHF/心肌梗死比值与年龄和既往心肌梗死病史相关解释(P < 0.05)。
  • 在7项按有无既往心血管疾病分层报告事件的试验中,HHF/心肌梗死和HHF/卒中比值在两组间相似。

局限性

  • 试验人群富集了心血管事件高风险者,限制了结果的普遍性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Emerging evidence points to heart failure as being a common first presentation of cardiovascular (CV) disease in type 2 diabetes. PURPOSE: The purpose of this study was to determine whether hospitalization for heart failure (HHF) occurs more or less frequently than major adverse CV events (MACE) in people with type 2 diabetes. DATA SOURCES: Placebo arms of CV outcomes trials in type 2 diabetes were included. STUDY SELECTION: Sixteen CV outcomes trials were selected, including five dipeptidyl peptidase 4 inhibitor trials, seven glucagon-like peptide 1 receptor agonist trials, and four sodium-glucose cotransporter 2 inhibitor trials. DATA EXTRACTION: We extracted incidence rates of HHF, myocardial infarction (MI), stroke, and the composite outcomes of CV death or HHF and MACE (CV death, nonfatal MI, or nonfatal stroke). DATA SYNTHESIS: In two trials enriched with people with chronic kidney disease, HHF was more common than both MI and stroke. Among the remaining 14 trials, HHF was less frequent than MI in 13 (93%), with this difference being significant in 8 (57%); however, HHF surpassed stroke in all but 1 study (93%; significant in 7 studies [50%]). Heterogeneity among trials was moderate/high (I 2 >50%) and partly explained by HHF/MI correlating with age and previous MI history (P < 0.05). In seven trials that reported events stratified by presence/absence of preexisting CV disease, ratios of HHF/MI and HHF/stroke were similar between groups. LIMITATIONS: Enrichment of trial populations with those at high risk of CV events limits generalizability. CONCLUSIONS: Although less frequent than MI, HHF is a common event in type 2 diabetes, both in those with and those without prior CV disease.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Sacre JW, Magliano DJ, Shaw JE, et al. Incidence of Hospitalization for Heart Failure Relative to Major Atherosclerotic Events in Type 2 Diabetes: A Meta-analysis of Cardiovascular Outcomes Trials. Diabetes Care. 2020. PMID: 32958618. doi:10.2337/dc20-0654

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。